OBJECTIVE: To assess the relationship between congenital heart disease (CHD) and Down syndrome (DS) in utero. DESIGN: Retrospective case series. SUBJECTS: Fifty-two fetuses with a cytogenetic diagnosis of DS managed at our Fetal Cardiology Unit in the study period. In particular, two populations of fetuses with DS were studied: a group of 41 DS fetuses referred to our unit for fetal echocardiography due to the chromosomal anomaly and a second group of 274 fetuses referred because of suspected CHD, 11 of which were found to have DS. METHODS: All fetuses were submitted to detailed ultrasound evaluation of fetal anatomy. Associated extracardiac anomalies, and presence and type of CHD, were recorded for all fetuses. Karyotyping was obtained by means of cordocentesis or amniocentesis. Necropsy or neonatal echocardiograms were sought for confirmation of the prenatal diagnosis. RESULTS: In the group of 41 fetuses with known DS, the incidence of CHD was 56% ([atrioventricular septal defect (AVSD) 44%, ventricular septal defect (VSD) 48%], the remainder having other heart defects). Conversely, considering the incidence of DS in fetuses with CHD, 43% of all AVSDs (53% of AVSD with normal visceral situs) were associated with DS, whereas none of the 39 cases of VSD was associated with trisomy 21. Ventricular septal defects were diagnosed only in fetuses referred to our center with a known diagnosis of aneuploidy. CONCLUSIONS: We have confined that more than half of the fetuses with DS bear a CHD, which is an AVSD in 44% of cases. Conversely, 43% of fetuses with an AVSD have trisomy 21. For VSDS, the situation is controversial, due to the relatively low detection level of this heart defect at the routine mid-trimester obstetric scan.
OBJECTIVE: To assess the relationship between congenital heart disease (CHD) and Down syndrome (DS) in utero. DESIGN: Retrospective case series. SUBJECTS: Fifty-two fetuses with a cytogenetic diagnosis of DS managed at our Fetal Cardiology Unit in the study period. In particular, two populations of fetuses with DS were studied: a group of 41 DS fetuses referred to our unit for fetal echocardiography due to the chromosomal anomaly and a second group of 274 fetuses referred because of suspected CHD, 11 of which were found to have DS. METHODS: All fetuses were submitted to detailed ultrasound evaluation of fetal anatomy. Associated extracardiac anomalies, and presence and type of CHD, were recorded for all fetuses. Karyotyping was obtained by means of cordocentesis or amniocentesis. Necropsy or neonatal echocardiograms were sought for confirmation of the prenatal diagnosis. RESULTS: In the group of 41 fetuses with known DS, the incidence of CHD was 56% ([atrioventricular septal defect (AVSD) 44%, ventricular septal defect (VSD) 48%], the remainder having other heart defects). Conversely, considering the incidence of DS in fetuses with CHD, 43% of all AVSDs (53% of AVSD with normal visceral situs) were associated with DS, whereas none of the 39 cases of VSD was associated with trisomy 21. Ventricular septal defects were diagnosed only in fetuses referred to our center with a known diagnosis of aneuploidy. CONCLUSIONS: We have confined that more than half of the fetuses with DS bear a CHD, which is an AVSD in 44% of cases. Conversely, 43% of fetuses with an AVSD have trisomy 21. For VSDS, the situation is controversial, due to the relatively low detection level of this heart defect at the routine mid-trimester obstetric scan.
Authors: Fernanda Teixeira da Silva Bellucco; Sintia Iole Nogueira Belangero; Leila Montenegro Silveira Farah; Maria Virgínia Lima Machado; Adriano Pastor Cruz; Lílian Maria Lopes; Marco Antonio Borges Lopes; Marcelo Zugaib; Mirlene Cecília Cernach; Maria Isabel Melaragno Journal: Pediatr Cardiol Date: 2010-09-17 Impact factor: 1.655
Authors: Irene C Joziasse; Kelly A Smith; Sonja Chocron; Maarten van Dinther; Victor Guryev; Jasper J van de Smagt; Edwin Cuppen; Peter Ten Dijke; Barbara Jm Mulder; Cheryl L Maslen; Benjamin Reshey; Pieter A Doevendans; Jeroen Bakkers Journal: Eur J Hum Genet Date: 2011-01-19 Impact factor: 4.246
Authors: Rong Mao; Xiaowen Wang; Edward L Spitznagel; Laurence P Frelin; Jason C Ting; Huashi Ding; Jung-whan Kim; Ingo Ruczinski; Thomas J Downey; Jonathan Pevsner Journal: Genome Biol Date: 2005-12-16 Impact factor: 13.583
Authors: Josephat M Chinawa; John C Eze; Ikechukwu Obi; Ijeoma Arodiwe; Fortune Ujunwa; Adiele K Daberechi; Herbert A Obu Journal: BMC Res Notes Date: 2013-11-19
Authors: Clémentine Ripoll; Isabelle Rivals; Emilie Ait Yahya-Graison; Luce Dauphinot; Evelyne Paly; Clothilde Mircher; Aimé Ravel; Yann Grattau; Henri Bléhaut; André Mégarbane; Guy Dembour; Bénédicte de Fréminville; Renaud Touraine; Nicole Créau; Marie Claude Potier; Jean Maurice Delabar Journal: PLoS One Date: 2012-08-09 Impact factor: 3.240
Authors: Ori Shen; Sari Lieberman; Benjamin Farber; Daniel Terner; Amnon Lahad; Ephrat Levy-Lahad Journal: J Clin Med Date: 2014-04-23 Impact factor: 4.241